How the product works:
Inhibits androgen receptors, blocking testosterone effect on tumour cells
Slows down cancer cell growth and division
May be used in combination with hormone therapy or chemotherapy
Recommended for:
Men diagnosed with metastatic or non-metastatic castration-resistant prostate cancer
Patients requiring extended androgen deprivation therapy
As prescribed by an oncologist
Metastatic castration-resistant prostate cancer
Non-metastatic castration-resistant prostate cancer
Taken orally, with or without food, following the prescribed regimen. Tablets should be swallowed whole with water at the same time each day.
Contraindications:
Hypersensitivity to Enzalutamide or any excipients
Severe hepatic impairment
Use in women and children
Women of childbearing potential
Side effects:
Fatigue
Headache
Seizures
High blood pressure
Diarrhoea
Hot flushes
Rash and skin reactions
